Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01728571 · ClinicalTrials.gov registry record · NA
LungVITamin D and OmegA-3 Trial (lungVITAL)
A NA study of Asthma and COPD, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- NA
- Development phase
- 25,871
- Enrollment target
- 1
- Study location
NCT01728571: Active NA study of Asthma and COPD, sponsored by Brigham and Women's Hospital.
NCT01728571 is a NA study of Asthma and COPD that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 25,871 participants, above the 1,494-participant average among 374 other Asthma trials with a reported enrollment target (1632% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01728571, a NA study of Asthma and COPD, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 25,871 participants
- Enrollment target
- 1
- Study location
Study Summary
The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is an ongoing randomized clinical trial in 25,871 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. This ancillary study is being conducted among participants in VITAL and will examine whether vitamin D or fish oil reduces respiratory morbidity, including COPD and asthma exacerbations, the risk of pneumonia, and airflow obstruction/decline of pulmonary function; and whether either of these interventions improves asthma control.
Primary Outcome
The primary questionnaire-based outcome was COPD respiratory exacerbations, defined for those with COPD as the number of episodes in the past 12 months of a flare-up of chest trouble treated with additional antibiotic or steroid medication at home, or resulting in hospitalization
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Vitamin D3
- DIETARY_SUPPLEMENT Vitamin D3 placebo
- DIETARY_SUPPLEMENT Fish oil placebo
- DIETARY_SUPPLEMENT fish oil
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25,871 participants |
| Start Date | 2010-07 |
| Est. Completion | 2025-02 |
| Phase | NA |
What the registry record for NCT01728571 still lists
NCT01728571 is an interventional study that assigns participants to a tested intervention. Its 25,871 participants enrollment target places it among the larger protocols in the corpus, above the 1,494-participant average among 374 other Asthma trials with a reported enrollment target (1632% higher).
The record links to 4 conditions, with Asthma appearing as the primary indexed condition, and to 4 interventions - of which Vitamin D3 is the first listed.
NCT01728571 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01728571 about?
NCT01728571 is a clinical study titled "LungVITamin D and OmegA-3 Trial (lungVITAL)". The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is an ongoing randomized clinical trial in 25,871 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer, heart dis...
What is the current status of trial NCT01728571?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 25,871 participants. The study started on 2010-07. Estimated completion is 2025-02.
What conditions does trial NCT01728571 study?
This clinical trial studies the following conditions: Asthma, COPD, Pneumonia, Pulmonary Function.
What interventions are being tested in trial NCT01728571?
The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT), Vitamin D3 placebo (DIETARY_SUPPLEMENT), Fish oil placebo (DIETARY_SUPPLEMENT), fish oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01728571?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01728571 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01728571's enrollment target sits among peer trials
25,871 4th of 374 higher than 371 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- NCT04994015 · 25,000 participants
Parkinson's Foundation PD GENEration Genetic Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia